Bibliografía
28. Petersen, A., Lupton, D. (2000). Op. cit., p. 25. 29. Furedi, F. (2018). How Fear Works. London: Bloomsberry Continuum, (p. 151 en versión Kindle).
1.Castoriadis, C. (1997). El Avance de la Insignificancia. Buenos Aires: EUDEBA, p.. 256.
30. Furedi, F. (1997). Culture o f Fear. London: Cassell. 31. Bauman, Z., Donskis, (2019). Op. cit., p. 60.
2. Rodríguez-Arias, D. (2014). La bioética global. Una ampliación de la agenda para la bioética. Dilemata, 6 (15): 233-241. p. 236.
32. Dela Ravanal, M., Aurenque, D.S. (2018). Medicalización, prevención y cuerpos sanos: la actualidad de los aportes de Illich y Foucault. Tópicos (México). https://doi.org/10.21555/top.v0i55.914. Accesado Agosto 17, 2020.
3. Savulescu J. (2015) Bioethics: why philosophy is essential for progress. Journal of Medical Ethics, 41:28–33. P. 3-5. 4. Hedgecoe, A.M. (2004). Critical bioethics: beyond the social science critique of applied ethics. Bioethics 18(2): 120-143, p.125.
33. Jonas H. (1995). El principio responsabilidad. Barcelona: Herder Editorial.
5. Dawson A. (2010). The future of bioethics: three dogmas and a cup of hemlock. Bioethics 24 (5): 218-225.
34. Bauman, Z. Donskis, L. (2017) Moral Blindness. Cambridge: Polity Press, p. 107.
6. Macklin, R. (2010). The death of bioethics (as we once knew it). Bioethics 24(5): 211-217.
35. D’Agostino, F.D. (20022). Bioética y derecho. Acta Bioethica VIII (2): 177-182, p. 181.
7. Maldonado, C.E. (2012). Crisis of bioethics and bioethics in the midst of crises. Revista Latinoamericana de Bioética 12 (1): 112-123.
36. Carleton, R.N. (2016). Fear of the Unkown: One Fear to Rule them All? Journal of anxiety disorders, 41:5-21.
8. Margaret E Kruk, M.E., Ataguba, J.E., Akweongo, P. (2020). The universal health coverage ambition faces a critical test. The Lancet DOI:https:// doi.org/10.1016/S0140-6736(20)31795-5. Accesado Septiembre 03, 2020.
37. Tudor, A. (2003). A (macro) sociology of fear. Sociological Review 51 (2): 238-256, p.251. 38. Hottois, G. (2001). Bioéthique. En Hottois, G., Missa J-N. Eds). Nouvelle encyclopédie de bioéthque. Bruxelles: De Boeck Université,124-131, p. 124.
9. Varsi Respigliosi, Rosenvald N., Torres Maldonado, M.A. (2020). La pandemia de la covid-19, la fuerza mayor y la alteración de las circunstancias en materia contractual. Acta Bioethica 26(1): 29-36, p. 30. 10. Marin , C. (2020). Réapprendre la maladie. Esprit (Mayo): 55-60,p-55.
39. Rojs, A.O., Labra, L. (2014). ¿Ética, bioética o ética médica? Revista chilena de enfermedades respiratorias 30(2): 91-94, p. 92. 40. González, J. (2002). Ética y Bioética. Isegoría 27: 41-53, p. 41.
11. Fritz, Z. (2020). Ethical road map through the covid-19 pandemic. British Medical Journal. DOI 10.1136/bmj. m2033.
41. Potter, V.R. (1971). Bioethics. Bridge to the Future. Englewood Cliffs: Prentice-Hall, p.
12. Häyry, M. (2020). The COVID-19 Pandemic: Healthcare Crisis Leadership as Ethics Communication. Cambridge Quarterly of Healthcare Ethics doi: 10.1017/S0963180120000444.
42. Elliot, C. (2001). Throwing a Bone to the Watchdog. The Hastings Center Report 31 (2):9-12 ).
13. Gourevitch, V. (2000). Rousseau on Providence. The Review of Metaphysics, 53(3), 565-611, p. 592. Accesado August 10, 2020.
43. Schaffer J-M. (2009). El fin de la excepción humana. Buenos Aires: Fondo de cultura Económica de Argentina, p. 45.
14. Potter, V.R. (1962). Bridge to the Future: The Concept of Human Progress. Journal of Land Economics 38: 1-8.
44. Ibid., p. 26. 45. Levine, R.J. (1979) Clarifying the Concepts of Research Ethics. The Hastings Center Report 9(3): 21-26.
15. Holland, S. (2007): Public health ethics. Cambridge: Polity Press. 16. Huxtable, R. (2020). COVID-19: where is the national ethical guidance. BMCMedical. Ethics https://covid19.elsevierpure.com/es/publications/ covid-19-where-is-the-nationalethical-guidance 21. Accesado Julio 15, 2020.
46 Maliandi, R. (2004). Ética: conceptos y problemas. Buenos Aires:Editorial Biblos, p. 70. 47. Chow-White, P.A., MacAulay, M., Charters, A., Chow, P. (2015). From bench to the bedside in the big data age: ethics and practices of consent and privacy for clinical genomics and personalized medicine. Ethics and Information Technology 17: 189-200, p.187.
17. Fritz, Z., Huxtable, R., Paton, A., Slowther, A., Wilkinson, D. (2020). Ethical road map through the covid-19 pandmemic. British Medical Journal https://doi.org/10.1136/bmj.m2033 (Published 21 May 2020) Accesado Julio 15, 2020.
48. Coekelbergh, M. (2010). Healthcare, Capabilities, and AI Assistive Technologies. Ethical Theory and Moral Practice 13: 181-190,p. 183.
18. Blumenthal-Barby, J. et al. (2020). Pandemic medical ethics. Journal of Medical Ethics. 46 (6): 353-354.
49. Bostrom N., Yukowsky, E. (2011). The Ethics of Artificial Intelligence. https://www.nickbostrom.com/ethics/artificial-intelligence.pdf. p. 18. Accesado Agosto 26, 2020.
19. Ienca, M., Andorno, R. (2017). Towards new human rights in the age of neuroscience and neurotechnology. Life Sciences, Society and Policy. DOI 10.1186/s40504-017-0050-1. Accesado Julio 20, 2020. 20. Dawson, A., Emanuel, E.J., Parker, M., Smith, M.J., Voo, T. C. (2020). Key Ethical Concepts and Their Application to COVID-19 Research. Public Health Ethics. DOI 10.1093/phe/phaa017, p. 1.
50. Galas, D.J., Hood, L. (2009). Systems Biology and Emerging Technologies Will Catalize the Transition from Reactive Medicine to Predictive, Personalized, Preventive and Participatory (P4) Medicine. Interdisciplinary Bio Central, 1(2): 1-4.
21. Bourdieu, P., Wacquant, L. .(2005). Una invitación a la sociología reflexiva. Buenos Aires: Siglo Veintiuno Editores Argentina.
51. Sadin É. (2018). L’Intelligence artificielle ou l’enjeu du siècle. Paris, L’Échappée, p.114.
22. Rogers, W. (2019). Bioethics and activism: A natural fit? Bioethics DOI: 10.1111/bioe.12558m p. 883.
52. Sadin (2008), op. cit., p. 259.
23. Epstein, M. (2010). How will the ecnomic downturn affect academic bioethics? Bioethics 24(5): 226-233.
53. Borenstein, J., Pearson, Y. (2010). Robot caregivers: harbingers of expanded freedom for all? Ethics Information Technology 12: 277-288. DOI 10.1007//s10676-010-9236-4.
24. Bauman, Z. y Donskis, L. (2019), Maldad líquida. Buenos Aires: Paidós, p.49.
54. Broekman, J.M. (2019) Rethinking Law and Language. Cheltenham: Edward Elgar Publishing Inc., p. 201.
25. Petersen y Lupton (2000). The new public health. Londo: Sage Publications, op. cit., p.167.
55. Agamben G. (2005). Profanaciones. 3ª ed. Buenos Aires: Adriana Hidalgo editora, p.97.
26. Petersen, A., Lupton, D. (2000). Op. cit., p. 23.
56. Junges, J. R. (2016) Hermenéutica como profanación de los nuevos sagrados: desafío y tarea para la bioética. Revista bioética, 24 (1): 22-28, p. 28.
27. James, J.E. (2014). Personalised medicine, disease prevention, and the inverse care law: more harm than benefits? European Journal of Epidemiology 29: 383-390.
57. Cochrane, A. (2010). Undignifid bioethics. Bioethics 24(5): 234-241, p. 241.
28
